RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models

Abstract Dopamine D2 receptor signaling is central for striatal function and movement, while abnormal activity is associated with neurological disorders including the severe early‐onset DYT1 dystonia. Nevertheless, the mechanisms that regulate D2 receptor signaling in health and disease remain poorl...

Full description

Saved in:
Bibliographic Details
Main Authors: Paola Bonsi, Giulia Ponterio, Valentina Vanni, Annalisa Tassone, Giuseppe Sciamanna, Sara Migliarini, Giuseppina Martella, Maria Meringolo, Benjamin Dehay, Evelyne Doudnikoff, Venetia Zachariou, Rose E Goodchild, Nicola B Mercuri, Marcello D'Amelio, Massimo Pasqualetti, Erwan Bezard, Antonio Pisani
Format: Article
Language:English
Published: Springer Nature 2018-12-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.201809283
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850104075641683968
author Paola Bonsi
Giulia Ponterio
Valentina Vanni
Annalisa Tassone
Giuseppe Sciamanna
Sara Migliarini
Giuseppina Martella
Maria Meringolo
Benjamin Dehay
Evelyne Doudnikoff
Venetia Zachariou
Rose E Goodchild
Nicola B Mercuri
Marcello D'Amelio
Massimo Pasqualetti
Erwan Bezard
Antonio Pisani
author_facet Paola Bonsi
Giulia Ponterio
Valentina Vanni
Annalisa Tassone
Giuseppe Sciamanna
Sara Migliarini
Giuseppina Martella
Maria Meringolo
Benjamin Dehay
Evelyne Doudnikoff
Venetia Zachariou
Rose E Goodchild
Nicola B Mercuri
Marcello D'Amelio
Massimo Pasqualetti
Erwan Bezard
Antonio Pisani
author_sort Paola Bonsi
collection DOAJ
description Abstract Dopamine D2 receptor signaling is central for striatal function and movement, while abnormal activity is associated with neurological disorders including the severe early‐onset DYT1 dystonia. Nevertheless, the mechanisms that regulate D2 receptor signaling in health and disease remain poorly understood. Here, we identify a reduced D2 receptor binding, paralleled by an abrupt reduction in receptor protein level, in the striatum of juvenile Dyt1 mice. This occurs through increased lysosomal degradation, controlled by competition between β‐arrestin 2 and D2 receptor binding proteins. Accordingly, we found lower levels of striatal RGS9‐2 and spinophilin. Further, we show that genetic depletion of RGS9‐2 mimics the D2 receptor loss of DYT1 dystonia striatum, whereas RGS9‐2 overexpression rescues both receptor levels and electrophysiological responses in Dyt1 striatal neurons. This work uncovers the molecular mechanism underlying D2 receptor downregulation in Dyt1 mice and in turn explains why dopaminergic drugs lack efficacy in DYT1 patients despite significant evidence for striatal D2 receptor dysfunction. Our data also open up novel avenues for disease‐modifying therapeutics to this incurable neurological disorder.
format Article
id doaj-art-aead3905e88349bb9ef74acccad80c03
institution DOAJ
issn 1757-4676
1757-4684
language English
publishDate 2018-12-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj-art-aead3905e88349bb9ef74acccad80c032025-08-20T02:39:24ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842018-12-0111111910.15252/emmm.201809283RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse modelsPaola Bonsi0Giulia Ponterio1Valentina Vanni2Annalisa Tassone3Giuseppe Sciamanna4Sara Migliarini5Giuseppina Martella6Maria Meringolo7Benjamin Dehay8Evelyne Doudnikoff9Venetia Zachariou10Rose E Goodchild11Nicola B Mercuri12Marcello D'Amelio13Massimo Pasqualetti14Erwan Bezard15Antonio Pisani16Laboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa LuciaLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa LuciaLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa LuciaLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa LuciaLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa LuciaUnit of Cell and Developmental Biology, Department of Biology, University of PisaLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa LuciaLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa LuciaUniversité de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount SinaiDepartment of Neurosciences, VIB‐KU Leuven Center for Brain and Disease Research, KU LeuvenLaboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa LuciaLaboratory Molecular Neurosciences, IRCCS Fondazione Santa LuciaUnit of Cell and Developmental Biology, Department of Biology, University of PisaUniversité de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293Laboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa LuciaAbstract Dopamine D2 receptor signaling is central for striatal function and movement, while abnormal activity is associated with neurological disorders including the severe early‐onset DYT1 dystonia. Nevertheless, the mechanisms that regulate D2 receptor signaling in health and disease remain poorly understood. Here, we identify a reduced D2 receptor binding, paralleled by an abrupt reduction in receptor protein level, in the striatum of juvenile Dyt1 mice. This occurs through increased lysosomal degradation, controlled by competition between β‐arrestin 2 and D2 receptor binding proteins. Accordingly, we found lower levels of striatal RGS9‐2 and spinophilin. Further, we show that genetic depletion of RGS9‐2 mimics the D2 receptor loss of DYT1 dystonia striatum, whereas RGS9‐2 overexpression rescues both receptor levels and electrophysiological responses in Dyt1 striatal neurons. This work uncovers the molecular mechanism underlying D2 receptor downregulation in Dyt1 mice and in turn explains why dopaminergic drugs lack efficacy in DYT1 patients despite significant evidence for striatal D2 receptor dysfunction. Our data also open up novel avenues for disease‐modifying therapeutics to this incurable neurological disorder.https://doi.org/10.15252/emmm.201809283beta‐arrestinlysosomal degradationstriatum
spellingShingle Paola Bonsi
Giulia Ponterio
Valentina Vanni
Annalisa Tassone
Giuseppe Sciamanna
Sara Migliarini
Giuseppina Martella
Maria Meringolo
Benjamin Dehay
Evelyne Doudnikoff
Venetia Zachariou
Rose E Goodchild
Nicola B Mercuri
Marcello D'Amelio
Massimo Pasqualetti
Erwan Bezard
Antonio Pisani
RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models
EMBO Molecular Medicine
beta‐arrestin
lysosomal degradation
striatum
title RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models
title_full RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models
title_fullStr RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models
title_full_unstemmed RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models
title_short RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models
title_sort rgs9 2 rescues dopamine d2 receptor levels and signaling in dyt1 dystonia mouse models
topic beta‐arrestin
lysosomal degradation
striatum
url https://doi.org/10.15252/emmm.201809283
work_keys_str_mv AT paolabonsi rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT giuliaponterio rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT valentinavanni rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT annalisatassone rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT giuseppesciamanna rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT saramigliarini rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT giuseppinamartella rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT mariameringolo rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT benjamindehay rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT evelynedoudnikoff rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT venetiazachariou rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT roseegoodchild rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT nicolabmercuri rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT marcellodamelio rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT massimopasqualetti rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT erwanbezard rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels
AT antoniopisani rgs92rescuesdopamined2receptorlevelsandsignalingindyt1dystoniamousemodels